Glycogen synthase kinase 3β activation is a prerequisite signal for cytokine production and chemotaxis in human mast cells

Journal of Immunology

Volumn 184, Issue 2, 2010, Pages 564-572

  Rådinger, Madeleine ^a   Kuehn, Hye Sun ^a   Kim, Mi Sun ^a   Metcalfe, Dean D ^a   Gilfillan, Alasdair M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 8; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; SHORT HAIRPIN RNA; STEM CELL FACTOR RECEPTOR; ACTIVATING TRANSCRIPTION FACTOR 2; ATF2 PROTEIN, HUMAN; CYTOKINE; GLYCOGEN SYNTHASE KINASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CELL ACTIVATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MAST CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; BIOSYNTHESIS; CELL CULTURE; IMMUNOLOGY; METABOLISM;

ACTIVATING TRANSCRIPTION FACTOR 2; CELLS, CULTURED; CHEMOTAXIS; CYTOKINES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAST CELLS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-KIT; SIGNAL TRANSDUCTION;

EID: 76249130928     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902931     Document Type: Article

References (39)

1. Mekori, Y. A., and D. D. Metcalfe. 2000. Mast cells in innate immunity. Immunol. Rev. 173: 131-140.
2. Metcalfe, D. D. 2008. Mast cells and mastocytosis. Blood 112: 946-956.
3. Okayama, Y., and T. Kawakami. 2006. Development, migration, and survival of mast cells. Immunol. Res. 34: 97-115.
4. Nilsson, G., J. H. Butterfield, K. Nilsson, and A. Siegbahn. 1994. Stem cell factor is a chemotactic factor for human mast cells. J. Immunol. 153: 3717-3723. (Pubitemid 24313877)
5. Ali, K., A. Bilancio, M. Thomas, W. Pearce, A. M. Gilfillan, C. Tkaczyk, N. Kuehn, A. Gray, J. Giddings, E. Peskett, et al. 2004. Essential role for the p110δ phosphoinositide 3-kinase in the allergic response. Nature 431: 1007-1011.
6. Hundley, T. R., A. M. Gilfillan, C. Tkaczyk, M. V. Andrade, D. D. Metcalfe, and M. A. Beaven. 2004. Kit and FcεRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood 104: 2410-2417.
7. Vosseller, K., G. Stella, N. S. Yee, and P. Besmer. 1997. c-kit receptor signaling through its phosphatidylinositide-3′-kinase-binding site and protein kinase C: role in mast cell enhancement of degranulation, adhesion, and membrane ruffling. Mol. Biol. Cell 8: 909-922.
8. Roskoski, R., Jr. 2005. Structure and regulation of Kit protein-tyrosine kinase - the stem cell factor receptor. Biochem. Biophys. Res. Commun. 338: 1307-1315.
9. Roskoski, R., Jr. 2005. Signaling by Kit protein-tyrosine kinase - the stem cell factor receptor. Biochem. Biophys. Res. Commun. 337: 1-13.
10. Jensen, B. M., C. Akin, and A. M. Gilfillan. 2008. Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders. Br. J. Pharmacol. 154: 1572-1582.
11. Linnekin, D. 1999. Early signaling pathways activated by c-Kit in hematopoietic cells. Int. J. Biochem. Cell Biol. 31: 1053-1074.
12. Kim, M. S., H. S. Kuehn, D. D. Metcalfe, and A. M. Gilfillan. 2008. Activation and function of the mTORC1 pathway in mast cells. J. Immunol. 180: 4586-4595.
13. Cohen, P., and M. Goedert. 2004. GSK3 inhibitors: development and therapeutic potential. Nat. Rev. Drug Discov. 3: 479-487.
14. Doble, B. W., and J. R. Woodgett. 2003. GSK-3: tricks of the trade for a multitasking kinase. J. Cell Sci. 116: 1175-1186.
15. Hu, X., P. K. Paik, J. Chen, A. Yarilina, L. Kockeritz, T. T. Lu, J. R.Woodgett, and L. B. Ivashkiv. 2006. IFN-γ suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 24: 563-574.
16. Kirshenbaum, A. S., J. P. Goff, T. Semere, B. Foster, L. M. Scott, and D. D. Metcalfe. 1999. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood 94: 2333-2342.
17. + pluripotent progenitor cells. Methods Mol. Biol. 315: 105-112.
18. Tkaczyk, C., D. D. Metcalfe, and A. M. Gilfillan. 2002. Determination of protein phosphorylation in Fc ε RI-activated human mast cells by immunoblot analysis requires protein extraction under denaturing conditions. J. Immunol. Methods 268: 239-243.
19. Hoeflich, K. P., J. Luo, E. A. Rubie, M. S. Tsao, O. Jin, and J. R.Woodgett. 2000. Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation. Nature 406: 86-90.
20. Jensen, B. M., M. A. Beaven, S. Iwaki, D. D. Metcalfe, and A. M. Gilfillan. 2008. Concurrent inhibition of kit- and FcεRI-mediated signaling: coordinated suppression of mast cell activation. J. Pharmacol. Exp. Ther. 324: 128-138.
21. Hughes, K., E. Nikolakaki, S. E. Plyte, N. F. Totty, and J. R. Woodgett. 1993. Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J. 12: 803-808. (Pubitemid 23073729)
22. Harwood, A. J. 2001. Regulation of GSK-3: a cellular multiprocessor. Cell 105: 821-824.
23. Fiol, C. J., A. M. Mahrenholz, Y. Wang, R. W. Roeske, and P. J. Roach. 1987. Formation of protein kinase recognition sites by covalent modification of the substrate: molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase 3. J. Biol. Chem. 262: 14042-14048.
24. Frame, S., P. Cohen, and R. M. Biondi. 2001. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol. Cell 7: 1321-1327.
25. Okayama, Y., D. D. Hagaman, and D. D. Metcalfe. 2001. A comparison of mediators released or generated by IFN-γ-treated human mast cells following aggregation of Fc g RI or Fc ε RI. J. Immunol. 166: 4705-4712. (Pubitemid 32233758)
26. Inoki, K., H. Ouyang, T. Zhu, C. Lindvall, Y. Wang, X. Zhang, Q. Yang, C. Bennett, Y. Harada, K. Stankunas, et al. 2006. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126: 955-968.
27. Dann, S. G., A. Selvaraj, and G. Thomas. 2007. mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol. Med. 13: 252-259.
28. Shah, O. J., J. C. Anthony, S. R. Kimball, and L. S. Jefferson. 2000. 4E-BP1 and S6K1: translational integration sites for nutritional and hormonal information in muscle. Am. J. Physiol. Endocrinol. Metab. 279: E715-E729.
29. Sarbassov, D. D., D. A. Guertin, S. M. Ali, and D. M. Sabatini. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101.
30. Jacinto, E., V. Facchinetti, D. Liu, N. Soto, S. Wei, S. Y. Jung, Q. Huang, J. Qin, and B. Su. 2006. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127: 125-137.
31. Wullschleger, S., R. Loewith, and M. N. Hall. 2006. TOR signaling in growth and metabolism. Cell 124: 471-484.
32. Hata, D., J. Kitaura, S. E. Hartman, Y. Kawakami, T. Yokota, and T. Kawakami. 1998. Bruton's tyrosine kinase-mediated interleukin-2 gene activation in mast cells: dependence on the c-Jun N-terminal kinase activation pathway. J. Biol. Chem. 273: 10979-10987.
33. Samayawardhena, L. A., and C. J. Pallen. 2008. Protein-tyrosine phosphatase a regulates stem cell factor-dependent c-Kit activation and migration of mast cells. J. Biol. Chem. 283: 29175-29185.
34. Samayawardhena, L. A., J. Hu, P. L. Stein, and A. W. Craig. 2006. Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor. Cell. Signal. 18: 1447-1454.
35. Sundström, M., J. Alfredsson, N. Olsson, and G. Nilsson. 2001. Stem cell factor-induced migration of mast cells requires p38 mitogen-activated protein kinase activity. Exp. Cell Res. 267: 144-151.
36. Martin, M., K. Rehani, R. S. Jope, and S. M. Michalek. 2005. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6: 777-784.
37. Rodionova, E., M. Conzelmann, E. Maraskovsky, M. Hess, M. Kirsch, T. Giese, A. D. Ho, M. Zöller, P. Dreger, and T. Luft. 2007. GSK-3 mediates differentiation and activation of proinflammatory dendritic cells. Blood 109: 1584-1592.
38. Ohteki, T., M. Parsons, A. Zakarian, R. G. Jones, L. T. Nguyen, J. R. Woodgett, and P. S. Ohashi. 2000. Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3. J. Exp. Med. 192: 99-104.
39. Kitaura, J., K. Asai, M. Maeda-Yamamoto, Y. Kawakami, U. Kikkawa, and T. Kawakami. 2000. Akt-dependent cytokine production in mast cells. J. Exp. Med. 192: 729-740.